CELL REPROGRAMMING:

We are exploring the transient expression of pluripotency factors for age reversal, through targeted mRNA infusion.

 

MYOEditase

We are exploring an intramuscular gene editing strategy to modulate myostatin expression for the treatment of sarcopenia.

 

OPTIMIZED FOLLISTATIN mRNA

In addition to our initial gene therapy approach for sarcopenia, we are developing an optimized follistatin mRNA platform with self replicating technology to maximize treatment duration and efficacy.

 

NEXT GENERATION hTERT mRNA

Our research team is improving on our original telomerase gene therapy by offering a stable mRNA treatment incorporating both hTERT and hTERC genes for enhanced expression and rejuvenation.

 

SENESCENT CELL CLEARANCE

We are researching a unique senolytic strategy involving targeting of the TK gene in senescent cells - leading to the specific destruction of these cells without harming healthy tissue.